SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study

Necrotizing soft tissue infections (NSTI) have a 90-day mortality rate of 18–22%. Tools are needed for estimating the prognosis and severity of NSTI upon admission. We evaluated soluble urokinase-type plasminogen activator receptor (suPAR) levels at admission as a prognostic marker of NSTI severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Polzik, Peter, Grøndal, Olav, Tavenier, Juliette, Madsen, Martin B., Andersen, Ove, Hedetoft, Morten, Hyldegaard, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434142/
https://www.ncbi.nlm.nih.gov/pubmed/30911053
http://dx.doi.org/10.1038/s41598-019-41688-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434142/
https://www.ncbi.nlm.nih.gov/pubmed/30911053
http://dx.doi.org/10.1038/s41598-019-41688-y

Ejemplares similares